Waters Corporation Intrinsic Value – WATERS CORPORATION Reports 5.0% Revenue Increase and 2.6% Net Income Increase for Fourth Quarter of 2022.

Earnings report

Waters Corporation Intrinsic Value – WATERS CORPORATION ($NYSE:WAT) recently reported financial results for their fourth quarter of fiscal year 2022, ending February 15, 2023. The results showed a 5.0% increase in total revenue year over year to USD 227.1 million, and a 2.6% increase in net income to USD 858.5 million. The increase in revenue and net income was driven by strong performance across WATERS CORPORATION’s various product lines, including liquid chromatography-mass spectrometry (LC-MS), thermal mass flow controllers (TFC), and mass spectrometry (MS). The company saw significant demand for its lab automation systems and associated consumables, as well as its software solutions.

This allows the company to access new markets and further increase their market share in established ones. Overall, the fourth quarter financial results indicate positive growth for WATERS CORPORATION as they continue to build on their success. With their impressive portfolio of products and services, WATERS CORPORATION is well positioned to continue to increase its revenue and profits for many years to come.

Stock Price

On Wednesday, WATERS CORPORATION reported a 5.0% increase in revenues for the fourth quarter of 2022. The company’s stock opened at $341.0 and closed at $336.9, down by 0.7% from last closing price of $339.3. Net income also increased by 2.6% during the same period. This performance comes in the midst of a challenging economic environment, and is a sign that WATERS CORPORATION continues to be a reliable source of profits for its investors. The increase in revenues was driven by the company’s focus on cost efficiency and improving customer service.

Additionally, WATERS CORPORATION has made investments in technology and infrastructure to enhance its competitive positioning and deliver greater value to its customers. The company has made investments in areas such as research and development, product development, and customer service, which will help it to remain competitive in the marketplace and deliver further returns to its shareholders. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Waters Corporation. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Waters Corporation. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Waters Corporation. More…

Key Ratios Snapshot

Some of the financial key ratios for Waters Corporation are shown below. More…

Analysis – Waters Corporation Intrinsic Value

As part of GoodWhale’s analysis of WATERS CORPORATION‘s fundamentals, we have determined the intrinsic value of its share to be around $330.4. Our proprietary Valuation Line allowed us to make this calculation. Based on the current market conditions, we have concluded that WATERS CORPORATION stock is being traded at a fair price of $336.9, which is a slight overvaluation of 2.0%. More…

Peers

Waters Corporation is an American analytical instrument manufacturing company that specializes in liquid chromatography, mass spectrometry, and thermal analysis instruments. It has annual sales of over $2 billion and employs more than 6,000 people worldwide. Its products are used in the life sciences, pharmaceutical, and chemical industries. Waters Corporation’s main competitors are IQVIA Holdings Inc, Agilent Technologies Inc, Vijaya Diagnostic Centre Ltd.

– IQVIA Holdings Inc ($NYSE:IQV)

The company’s market cap as of 2022 was 39.27B and its ROE was 21.52%. The company is a global provider of information, innovative technology solutions, and real-world insights that help customers improve their well-being. The company offers a broad range of products and services that enable customers to manage their health and wellbeing.

– Agilent Technologies Inc ($NYSE:A)

Agilent Technologies, Inc. is a provider of life sciences, diagnostics, and applied chemical markets solutions. It operates through three segments: Life Sciences and Applied Markets Group, Diagnostics and Genomics Group, and Agilent CrossLab Group. The Life Sciences and Applied Markets Group segment offers application solutions that include chromatography, mass spectrometry, chemical analysis, and cellular analysis. The Diagnostics and Genomics Group segment provides in vitro diagnostic products and services. The Agilent CrossLab Group segment offers a range of services and consumables. Agilent Technologies was founded in 1999 and is headquartered in Santa Clara, California.

– Vijaya Diagnostic Centre Ltd ($BSE:543350)

Vijaya Diagnostic Centre Ltd is a leading diagnostic centre in India with a market cap of 46.61B as of 2022. The company has a return on equity of 17.7%. The company offers a wide range of diagnostic services including X-rays, ultrasounds, MRI, and CT scans. The company also has a wide network of centres across India.

Summary

Waters Corporation, a specialty measurement company, recently reported a noteworthy improvement in their financial performance. Total revenue increased by 5.0% year over year to USD 227.1 million, while net income increased 2.6% to USD 858.5 million, creating a positive outlook for the company. The strong financial results are likely to attract the attention of prospective investors, which could result in an increased demand for the company’s stock and better valuations. Investors should keep a close eye on Waters Corporation’s financial performance as it continues to make strides in the industry.